Abstract: Slip-down behavior from a raised platform of Slc:ddY mice was examined. Mice intraperioneally injected with 1 or 1.5 mg/kg of methamphetamine (MAP) slipped down from a raised platform of 10 cm diameter and 20 cm height within 5 min, 20 min after the injection. After pretreatment five times with 1 mg/kg MAP at intervals of 3 days, the slipdown was induced after injection of 0.5, 1 or 1.5 mg/kg MAP, but after pretreatment ten times with 1 mg/kg MAP at intervals of 3 days the behavior was not recognized at the same doses. These phenomena were like reverse-tolerance and tolerance. The situational change of the MAP treatments, placement on the platform after each pretreatment, did not affect the phenomena. The present findings strongly suggest that the slip-down is a behavior affected by the dose and number of administration of MAP, but not by the treatment situation. Key words: Slc:ddY mouse, methamphetamine, slip-down from a raised platform chased from Dainihon Seiyaku Co. Osaka, Japan. Physiological saline (PS), 200 µl , as a control or 0.5, 1 or 1.5 mg/kg of MAP were intraperitoneally respectively injected to one of four groups of 5 mice. Twenty minutes after the injection, each of these mice was placed on a raised platform (10 cm diameter, 20 cm height) and their behavior was investigated for 5 min. All of the mice moved about on the platform: forwards, backwards and changing body direction. Mice injected with PS or 0.5 mg/kg of MAP stopped at the edge of the platform, but mice injected with the 1 or 1.5 mg/kg MAP could not stop themselves at the edge and slippeddown from the platform within 5 min. None of the mice showed stereotypical behavior, sniffing and headbobbing, induced by MAP [4] .
chased from Dainihon Seiyaku Co. Osaka, Japan. Physiological saline (PS), 200 µl , as a control or 0.5, 1 or 1.5 mg/kg of MAP were intraperitoneally respectively injected to one of four groups of 5 mice. Twenty minutes after the injection, each of these mice was placed on a raised platform (10 cm diameter, 20 cm height) and their behavior was investigated for 5 min. All of the mice moved about on the platform: forwards, backwards and changing body direction. Mice injected with PS or 0.5 mg/kg of MAP stopped at the edge of the platform, but mice injected with the 1 or 1.5 mg/kg MAP could not stop themselves at the edge and slippeddown from the platform within 5 min. None of the mice showed stereotypical behavior, sniffing and headbobbing, induced by MAP [4] . We are interested in the behavior of Slc:ddY mice in various situations. Hui and Roberts found that mice administered morphine jump off a raised platform [2] . Both methamphetamine (MAP) and morphine induce interesting behavioral effects. We examined the behavior on a raised platform of Slc:ddY mice administered MAP.
Male Slc:ddY mice, 8 weeks old and weighing 26-28 g (SLC. Co. Shizuoka, Japan), were used. Five mice in a plastic cage (338 × 140 × 225 mm) freely took a solid food diet (F 2 : Funabashi Co. Funabashi, Japan) and water in a tapping bottle. The animal room was kept at 21-25°C with 50-60% humidity, lighting on from 7: 00 to 19: 00. The Ethics Committee for Animal Experiments of Akita University School of Medicine approved all of the studies. MAP was pur-Reverse-tolerance and tolerance phenomena are sometimes recognized in the behavior induced by MAP. Four groups of 5 mice were pretreated five times with 1 mg/kg of MAP at intervals of 3 days. Three days after the final treatment, PS, 0.5, 1 or 1.5 mg/kg of MAP was respectively injected to one of the four groups of mice. In these mice, injection of 0.5, 1 or 1.5 mg/kg of MAP induced the slip-down, but not the stereotypical behavior. A further 4 groups of mice were pretreated ten times with 1 mg/kg of MAP. These mice did not show the slip-down and the stereotypical behavior.
The reverse-tolerance and tolerance phenomena are often influenced by condition of the pretreatment. Four groups of five mice were administered PS ten times at intervals of 3 days. Another 4 groups of mice were treated five times with PS, then treated 5 times with 1 mg/kg of MAP at intervals of 3 days. A further 4 groups of mice were treated ten times with 1 mg/kg of MAP at intervals of 3 days. Mice from each group were individually placed on the platform for 5 min, 20 min after each treatment. In mice treated only with PS, the slip-down was not found in any of the investigation periods. In the mice treated five times with 1 mg/kg of MAP, the slip-down was found in the periods after the MAP treatments. In mice treated ten times with MAP, the slip-down was not recognized in the periods after the 9th and the 10th treatments. Three days after the 10th treatment the mice of each pretreatment group were individually injected with PS, 0.5, 1 or 1.5 mg/kg of MAP, and the slip-down was investigated 20 min after the injection. The phenomena like reverse-tolerance and tolerance were recognized the same as before.
The present findings are shown in Table 1 . They indicate that the slip-down of ddY mice was induced by MAP according to the dose and the number of administration, but was not affected by the treatment situation. If the slip-down is considered to be a result of increase of ambulation, the present findings agree with a previous report [3] . However, Hirabayashi et al. reported that the ambulation-increasing effect of MAP was significantly enhanced on platforms with diameters greater than 15 cm [1] . This may suggest that the slipdown has a behavioral meaning different from increase of the ambulation. Furthermore, the present findings strongly suggest that the slip-down is also a behavior associated with the reverse tolerance and tolerance, however, the pharmacological mechanism is not clear. 
